Effects of topical clonidine versus brimonidine on choroidal blood flow and intraocular pressure during squatting

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 9, 2007, Pages 4220-4225

  Weigert, Günther ^a   Resch, Hemma ^a   Garhofer, Gerhard ^a   Fuchsjäger Mayrl, Gabriele ^a   Schmetterer, Leopold ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE; CLONIDINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; QUINOXALINE DERIVATIVE;

ADULT; ARTICLE; BLOOD FLOW; BODY POSITION; BRAIN BLOOD FLOW; CHOROID VASCULARIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEMODYNAMICS; HUMAN; INTRAOCULAR PRESSURE; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; BLOOD FLOW VELOCITY; BODY POSTURE; CHOROID; COMPARATIVE STUDY; OCULOPLETHYSMOGRAPHY; TOPICAL DRUG ADMINISTRATION; VASCULARIZATION;

ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-AGONISTS; ADULT; BLOOD FLOW VELOCITY; CHOROID; CLONIDINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; POSTURE; QUINOXALINES; REGIONAL BLOOD FLOW; TONOMETRY, OCULAR;

EID: 35148895808     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0178     Document Type: Article

References (39)

1. David R. Brimonidine (alphagan): a clinical profile four years after launch. Eur J Ophthalmol. 2001;11:S72-S77.
2. Derick RJ, Robin AL, Walters TR, et al. Brimonidine tartrate: a one-month dose response study (published correction in Ophthalmology. 1997;104:346). Ophthalmology. 1997;104:131-136.
3. Schuman JS, Horwitz B, Choplin NT, David R, Albracht D, Chen K. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension: a controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group. Arch Ophthalmol. 1997;115:847-852.
4. Wheeler L, WoldeMussie E, Lai R. Role of alpha-2 agonists in neuroprotection. Surv Ophthalmol. 2003;48:S47-S51.
5. Robin AL. The role of alpha-agonists in glaucoma therapy. Curr Opin Ophthalmol. 1997;8:42-49.
6. Toris CB, Gleason ML, Camras CB, Yablonski ME. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol. 1995;113:1514-1517.
7. Lee DA, Topper JE, Brubaker RF. Effect of clonidine on aqueous humor flow in normal human eyes. Exp Eye Res. 1984;38:239-246.
8. Toris CB, Tafoya ME, Camras CB, Yablonski ME. Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology. 1995;102:456-461.
9. Toris CB, Camras CB, Yablonski ME. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. Am J Ophthalmol. 1999;128:8-14.
10. Wilensky JT. The role of brimonidine in the treatment of open-angle glaucoma. Surv Ophthalmol. 1996;41:S3-S7.
11. Yoles E, Wheeler LA, Schwartz M. Alpha 2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci. 1999;40:65-73.
12. Reitsamer HA, Posey M, Kiel JW. Effects of a topical alpha2 adrenergic agonist on ciliary blood flow and aqueous production in rabbits. Exp Eye Res. 2006;82:405-415.
13. Maus TL, Nau C, Brubaker RF. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents. Arch Ophthalmol. 1999;117:586-591.
14. Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359-393.
15. Wikberg-Matsson A, Simonsen U. Potent alpha(2A)-adrenoceptor-mediated vasoconstriction by brimonidine in porcine ciliary arteries. Invest Ophthalmol Vis Sci. 2001;42:2049-2055.
16. Rosa RH Jr, Hein TW, Yuan Z, et al. Brimonidine evokes heterogeneous vasomotor response of retinal arterioles: diminished nitric oxide-mediated vasodilation when size goes small. Am J Physiol. 2006;291:H231-H238.
17. Robinson F, Riva CE, Grunwald JE, Petrig BL, Sinclair SH. Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest Ophthalmol Vis Sci. 1986;27:722-726.
18. Maepea O. Pressures in the anterior ciliary arteries, choroidal veins and choriocapillaris. Exp Eye Res. 1992;54:731-736.
19. Reitsamer HA, Kiel JW. A rabbit model to study orbital venous pressure, intraocular pressure, and ocular hemodynamics simultaneously. Invest Ophthalmol Vis Sci. 2002;43:3728-3734.
20. Riva CE, Cranstoun SD, Grunwald JE, Petrig BL. Choroidal blood flow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci. 1994;35:4273-4281.
21. Bonner RF, Nossal R. Principles of laser-Doppler flowmetry. In: Sheperd AP, Oberg P, eds. Laser-Doppler Blood Flowmetry. Boston: Kluwer Academic Publishers; 1990; 17-46.
22. Geiser MH, Diermann U, Riva CE. Compact laser Doppler choroidal flowmeter. J Biomed Opt. 1999;4:459-464.
23. Riva CE, Grunwald JE Petrig BL. Autoregulation of human retinal blood flow: an investigation with laser Doppler velocimetry. Invest Ophthalmol Vis Sci. 1986;27:1706-1712.
24. Fuchsjager-Mayrl G, Luksch A, Malec M, Polska E, Wolzt M, Schmetterer L. Role of endothelin-1 in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci. 2003;44:728-733.
25. Luksch A, Polska E, Imhof A, et al. Role of NO in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci. 2003;44:734-739.
26. Polska E, Luksch A, Schering J, et al. Propranolol and atropine do not alter choroidal blood flow regulation during isometric exercise in healthy humans. Microvasc Res. 2003;65:39-44.
27. Wimpissinger B, Resch H, Berisha F, Weigert G, Polak K, Schmetterer L. Effects of isometric exercise on subfoveal choroidal blood flow in smokers and nonsmokers. Invest Ophthalmol Vis Sci. 2003;44:4859-4863.
28. Kiel JW, Shepherd AP. Autoregulation of choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 1992;33:2399-2410.
29. Grunwald JE, Sinclair SH, Riva CE. Autoregulation of the retinal circulation in response to decrease of intraocular pressure below normal. Invest Ophthalmol Vis Sci. 1982;23:124-127.
30. Findl O, Strenn K, Wolzt M, et al. Effects of changes in intraocular pressure on human ocular haemodynamics. Curr Eye Res. 1997;16:1024-1029.
31. Riva CE, Titze P, Hero M, Petrig BL. Effect of acute decreases of perfusion pressure on choroidal blood flow in humans. Invest Ophthalmol Vis Sci. 1997;38:1752-1760.
32. Grieshaber MC, Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol. 2005;16:79-83.
33. Kawarai M, Koss MC. Sympathetic vasoconstriction in the rat anterior choroid is mediated by alpha 1-adrenoceptors. Eur J Pharmacol. 1998;363:35-40.
34. Steinle JJ, Krizsan-Agbas D, Smith PG. Regional regulation of choroidal blood flow by autonomic innervation in the rat. Am J Physiol. 2000;279:R202-R209.
35. Robin AL, Burnstein Y. Selectivity of site of action and systemic effects of topical alpha agonists. Curr Opin Ophthalmol. 1998;9:30-33.
36. Costagliola C, Parmeggiani F, Ciancaglini M, D'Oronzo E, Mastropasqua L, Sebastiani A. Ocular perfusion pressure and visual field indice modifications induced by alpha-agonist compound (clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2%) topical administration: an acute study on primary open-angle glaucoma patients. Ophthalmologica. 2003;217:39-44.
37. Inan UU, Ermis SS, Yucel A, Ozturk F. The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3-month clinical trial. Acta Ophthalmol Scand. 2003;81:155-160.
38. Schmidt KG, Klingmuller V, Gouveia SM, Osborne NN, Pillunat LE. Short posterior ciliary artery, central retinal artery, and choroidal hemodynamics in brimonidine-treated primary open-angle glaucoma patients. Am J Ophthalmol. 2003;136:1038-1048.
39. Simsek T, Yanik B, Conkbayir I, Zilelioglu O. Comparative analysis of the effects of brimonidine and dorzolamide on ocular blood flow velocity in patients with newly diagnosed primary open-angle glaucoma. J Ocul Pharmacol Ther. 2006;22:79-85.